Insider Transactions in Q4 2025 at Quidel Ortho Corp (QDEL)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 10
2025
|
Ann D Rhoads Director |
BUY
Open market or private purchase
|
Direct |
750
+4.76%
|
$21,000
$28.27 P/Share
|
|
Nov 26
2025
|
Joseph D Wilkins Jr. Director |
BUY
Open market or private purchase
|
Direct |
370
+3.02%
|
$9,990
$27.95 P/Share
|
|
Nov 25
2025
|
Kenneth J Widder Director |
SELL
Open market or private sale
|
Direct |
4,026
-9.8%
|
$108,702
$27.81 P/Share
|
|
Nov 25
2025
|
Kenneth J Widder Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,021
+14.59%
|
$105,315
$15.74 P/Share
|
|
Nov 24
2025
|
Joseph M Busky Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
4,770
+40.8%
|
$124,020
$26.06 P/Share
|
|
Nov 21
2025
|
Mary Lake Ph D Polan Director |
BUY
Open market or private purchase
|
Direct |
1,000
+7.33%
|
$22,000
$22.43 P/Share
|
|
Nov 19
2025
|
Brian J Blaser President and CEO |
BUY
Open market or private purchase
|
Indirect |
23,500
+44.31%
|
$493,500
$21.34 P/Share
|
|
Nov 18
2025
|
Michelle A. Hodges Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,717
-7.82%
|
$57,057
$21.28 P/Share
|
|
Nov 18
2025
|
Michelle A. Hodges Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,349
+13.34%
|
-
|
|
Oct 15
2025
|
Jonathan Philip Siegrist EVP of R&D & CTO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,676
-35.78%
|
$180,252
$27.31 P/Share
|
|
Oct 15
2025
|
Jonathan Philip Siegrist EVP of R&D & CTO |
BUY
Grant, award, or other acquisition
|
Direct |
18,656
+50.0%
|
-
|
|
Oct 15
2025
|
Michelle A. Hodges Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
199
-0.67%
|
$5,373
$27.31 P/Share
|
|
Oct 15
2025
|
Michelle A. Hodges Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
390
+1.3%
|
-
|